SV Atlas
← All founders
Benedetta di Robilant

2x founder

Benedetta di Robilant

Co-founder and CEO at ProMIND Therapeutics | Former founder/CSO at Dorian Therapeutics (acquired by Altos Labs) | Stanford | YC

Co-founderDorian Therapeutics logoDorian Therapeutics· Summer 2018San Francisco Bay Area
in LinkedIn
2025Co-founder· ProMIND Therapeutics
Founder · since 2018
Company
ProMIND Therapeutics
Role
Co-founder and CEO
current
Stage
—
no public source
Raised
—
no public source
Based
—
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
Dorian Therapeutics logo
Dorian Therapeutics

New therapeutics to rejuvenate tissue and treat age-related diseases

Summer 2018

Experience

Career

  • ProMIND Therapeutics

    Co-founder

    Co-founder and CEO · 2025 – Present

    2025

  • Dorian Therapeutics [acquired by Altos Labs]

    Co-founder

    Co-Founder and CSO · San Francisco Bay Area · 2018 – 2025

    2018
  • Multiply Labs logo

    Multiply Labs

    Scientific Advisor · South San Francisco, California, United States · 2022 – 2025

    2022
  • StartX. logo

    StartX.

    Member S19 · Palo Ato, CA · 2019

    2019
  • Y Combinator logo

    Y Combinator

    Member of S18 Bio Program · San Francisco Bay Area · 2018

    2018
  • Stanford University School of Medicine logo

    Stanford University School of Medicine

    Postdoctoral Fellow · San Francisco Bay Area · 2015 – 2018

    2015
  • Stanford University School of Medicine logo

    Stanford University School of Medicine

    Visiting PhD Student, Stem Cell Biology and Regenerative Medicine · Stanford, CA · 2012 – 2013

    2012
  • Genentech logo

    Genentech

    Internship, Division of Tumor Biology and Angiogenesis · South San Francisco, CA · 2009

    2009